Editorial: intravenous to subcutaneous vedolizumab-switch without glitch!

Nadesalingam, Vinoth; Subramanian, Sreedhar

Nadesalingam, Vinoth; Subramanian, Sreedhar.

Nadesalingam V; Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
Subramanian S; Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

Aliment Pharmacol Ther ; 56(2): 349-350, 2022 07.

Article in English | MEDLINE | ID: covidwho-2152630

Subject(s)

Antibodies, Monoclonal, Humanized; Administration, Intravenous; Antibodies, Monoclonal, Humanized/adverse effects; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized Limits: Humans Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: Apt.16989

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google